- About Us
- Research & Pipeline
- Investor Centre
- Media Centre
Kazia has been in the news lately and we are pleased to share the key media items.
Our CEO, Dr James Garner was recently interviewed on Ausbiz to discuss Kazia’s entitlement offer, with the company successfully completing the institutional component of the offer last week, which raised $16.4 million.
Dr Garner told Ausbiz that the funds raised from both the institutional and retail offers would be used to fund the upcoming registration study for paxalisib, GBM AGILE. Dr Garner also discussed the recent awards from the US Food and Drug Administration for paxalisib.
You can watch the interview here.
Dr Garner was also interviewed by US financial publication, The Wall Street Transcript.
In the interview, Dr Garner discusses:
Read the article (subscriber only) here.
Kazia’s entitlement offer was also featured in Morgans analyst Scott Power’s column in Stockhead, with Mr Power noting that the successful raise shows that there’s still strong appetite for capital in the market.
Read the article here.